2014-04-17

Fosun Pharma ranked one of 2014 Top50 High-integrity Companies Listed on the Main Board


On April 13th, “The Power of Integrity” Listed Company Summit directed by the Association of China Economic Press and sponsored by www.ipo123.cn was held at the Chinese Academy of Governance. Among the top50 high-integrity listed companies selected by www.ipo123.cn, the Association of China Economic Press and China Information News, Fosun Pharma (600196) was honored as one of 2014 Top 50 High-integrity Companies Listed on the Main Board, which represents comprehensive evaluation by financial media to listed companies on their honest operation and standardized governance, commitment fulfillment, social responsibility and brand reputation, the recognition for Fosun’s standardized management and market image and the improvement of its brand image and market influence.


Putting emphasis on integrity building, Fosun Pharma has won such awards as Shanghai High-integrity Pharmaceutical Company, Shanghai High-integrity Bio-pharma Company and the 3rd CCB Cup Shanghai High-integrity Company Contributing to Housing Fund. With the heart of gratitude, Fosun Pharma is always committed to satisfying the society, government, its employees and shareholders. Since 2009, Fosun Pharma has published CSR reports for six years.


It is reported that the event received active response from a majority of listed companies. Strictly following the principle of being open, fair and just, the Organizing Committee disclosed a list of candidates group by group for one week through self-recommendation, public voting, expert review and nomination. On March 31st, the Organizing Committee finalized the top50 list including the high-integrity companies, brands and individuals.